Clinical Trial

Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device

Name: Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device — clinical trial record (NCT07701161)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study compares p-tau217 concentrations in blood collected via the Tasso device versus standard venipuncture in subjects with and without Alzheimer's disease, including a subset with confirmed amyloid pathology.

Trial Details

NCT Number	NCT07701161
Lead Sponsor	Neurogen Biomarking LLC
Conditions	Alzheimer s Disease, MCI Conversion to Dementia, pTau217, Biomarkers
Enrollment	1,000 participants
Start Date	2025-01-13
Primary Completion	2026-03-20 (estimated)
Study Completion	2026-08-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-14